Badings, Erik A <br/><br/>
Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population.  [electronic resource] 

 -  Journal of diabetes  Sep 2011 
 - 232-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1753-0407 
<br/><br/><label>Standard No.: </label>10.1111/j.1753-0407.2011.00124.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Glucose--metabolism<br/>Cardiovascular Diseases--blood<br/>Cross-Sectional Studies<br/>Diabetes Mellitus, Type 2--blood<br/>Fasting--blood<br/>Female<br/>Glucose Intolerance--blood<br/>Glucose Tolerance Test<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin Glargine<br/>Insulin, Long-Acting--therapeutic use<br/>Male<br/>Middle Aged<br/>Multicenter Studies as Topic<br/>ROC Curve<br/>Randomized Controlled Trials as Topic<br/>Risk Factors